doi: 10.1093/rheumatology/ker239.
Use of biologic agents in rheumatoid arthritis: introduction
Affiliations
- PMID: 21859703
- DOI: 10.1093/rheumatology/ker239
Item in Clipboard
Use of biologic agents in rheumatoid arthritis: introduction
Rheumatology (Oxford).
2011 Sep.
No abstract available
Similar articles
-
Comparative overview of safety of the biologics in rheumatoid arthritis.J Rheumatol Suppl. 2009 Jun;82:25-32. doi: 10.3899/jrheum.090128. J Rheumatol Suppl. 2009. PMID: 19509327 Review.
-
Development of the Birmingham Rheumatoid Arthritis Model: past, present and future plans.Rheumatology (Oxford). 2011 Sep;50 Suppl 4:iv32-iv38. doi: 10.1093/rheumatology/ker244. Rheumatology (Oxford). 2011. PMID: 21859704
-
The British Society for Rheumatology Biologics Register: 6 years on.Rheumatology (Oxford). 2008 Oct;47(10):1441-3. doi: 10.1093/rheumatology/ken242. Epub 2008 Jul 1. Rheumatology (Oxford). 2008. PMID: 18596052 No abstract available.
-
'Treat to target' for rheumatoid arthritis in 2014--time tested triple therapy or logical biologics?Int J Rheum Dis. 2014 Jan;17(1):1-3. doi: 10.1111/1756-185X.12313. Int J Rheum Dis. 2014. PMID: 24472259 No abstract available.
-
Is there a pharmacoeconomic argument supporting the use of tumor necrosis factor inhibitors in early rheumatoid arthritis?Nat Clin Pract Rheumatol. 2006 Jul;2(7):346-7. doi: 10.1038/ncprheum0218. Nat Clin Pract Rheumatol. 2006. PMID: 16932716 Review. No abstract available.
Cited by
-
Consensus Decision Models for Biologics in Rheumatoid and Psoriatic Arthritis: Recommendations of a Multidisciplinary Working Party.Rheumatol Ther. 2015 Dec;2(2):113-125. doi: 10.1007/s40744-015-0020-0. Epub 2015 Nov 25. Rheumatol Ther. 2015. PMID: 27747536 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
